Integrated analysis reveals an immune evasion prognostic signature for predicting the overall survival in patients with hepatocellular carcinoma
IEPS has strong prognostic value for HCC patients, and CAD and PIGU provide perspectives on new biomarkers and therapeutic targets for HCC.
Authors
- Jun Wen (ORCID: https://orcid.org/0000-0002-2678-7329)
- Weidong Wang (ORCID: https://orcid.org/0000-0002-0658-7928)
- Xing He (ORCID: https://orcid.org/0000-0001-7676-9930)
- Zhiyu Xiao (ORCID: https://orcid.org/0000-0003-0746-7116)
- Huoming Li
- Qiaohong Lin (ORCID: https://orcid.org/0009-0001-7591-5032)
- Yongcong Yan (ORCID: https://orcid.org/0000-0002-7269-764X)
- Haohan Liu (ORCID: https://orcid.org/0000-0003-0750-9304)
- Tao Meng (ORCID: https://orcid.org/0000-0003-1789-5245)
- Zheng Huang (ORCID: https://orcid.org/0000-0001-5143-5192)
- Zhenyu Zhou (ORCID: https://orcid.org/0000-0003-2280-9962)
- Kai Wen (ORCID: https://orcid.org/0009-0008-2464-6486)
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen Memorial Hospital (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1186/s12935-025-03743-9
- Citations
- 6
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 6.27
Funders
- National Natural Science Foundation of China